These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38479485)

  • 1. Comparative evaluation of physical and chemical enhancement techniques for transdermal delivery of linagliptin.
    Karve T; Banga AK
    Int J Pharm; 2024 Apr; 654():123992. PubMed ID: 38479485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis.
    Kale M; Kipping T; Banga AK
    Int J Pharm; 2020 Nov; 589():119853. PubMed ID: 32898633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedle Mediated Iontophoretic Delivery of Tofacitinib Citrate.
    Dandekar AA; Garimella HT; German CL; Banga AK
    Pharm Res; 2023 Mar; 40(3):735-747. PubMed ID: 35174431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride.
    Puri A; Murnane KS; Blough BE; Banga AK
    Int J Pharm; 2017 Aug; 528(1-2):452-462. PubMed ID: 28633107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Transdermal Delivery of N-Acetylcysteine and 4-Phenylbutyric Acid for Potential Use as Antidotes to Lewisite.
    Dandekar AA; Vora D; Yeh JS; Srivastava RK; Athar M; Banga AK
    AAPS PharmSciTech; 2023 Feb; 24(3):71. PubMed ID: 36828949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
    Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
    AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
    Singh ND; Banga AK
    J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
    Vora D; Banga AK
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedle system: a modulated approach for penetration enhancement.
    Khare N; Shende P
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1183-1192. PubMed ID: 34634991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of naloxone hydrochloride using minimally invasive physical ablation techniques.
    Tijani AO; Dandekar AA; Karve T; Banga AK; Puri A
    Int J Pharm; 2023 Jul; 642():123159. PubMed ID: 37336303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers.
    Datta D; Panchal DS; Venuganti VVK
    Int J Pharm; 2021 Jun; 602():120663. PubMed ID: 33933644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal iontophoresis of sodium nonivamide acetate. V. Combined effect of physical enhancement methods.
    Fang JY; Hwang TL; Huang YB; Tsai YH
    Int J Pharm; 2002 Mar; 235(1-2):95-105. PubMed ID: 11879744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis.
    Keerthi H; Panakanti PK; Yamsani MR
    PDA J Pharm Sci Technol; 2012; 66(4):318-32. PubMed ID: 22767881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of breakthrough therapeutics for the management of treatment-resistant and post-partum depression.
    Bhattaccharjee SA; Murnane KS; Banga AK
    Int J Pharm; 2020 Dec; 591():120007. PubMed ID: 33191204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of proteins.
    Kalluri H; Banga AK
    AAPS PharmSciTech; 2011 Mar; 12(1):431-41. PubMed ID: 21369712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
    Wang Y; Thakur R; Fan Q; Michniak B
    Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques.
    Lanke SS; Strom JG; Banga AK
    Crit Rev Ther Drug Carrier Syst; 2009; 26(6):581-606. PubMed ID: 20402624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle and iontophoresis mediated delivery of methotrexate into and across healthy and psoriatic skin.
    Vora D; Garimella HT; German CL; Banga AK
    Int J Pharm; 2022 Apr; 618():121693. PubMed ID: 35331833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.
    Meidan VM; Al-Khalili M; Michniak BB
    Int J Pharm; 2003 Oct; 264(1-2):73-83. PubMed ID: 12972337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.